Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer

There is currently no gene expression assay that can assess if premalignant lesions will develop into invasive breast cancer. This study sought to identify biomarkers for selecting patients with a high potential for developing invasive carcinoma in the breast with normal histology, benign lesions, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Qing, Wang, Jiajia, Ducatman, Barbara, Raese, Rebecca A., Rogers, Jillian L., Wan, Ying-Wooi, Dong, Chunlin, Padden, Lindsay, Pugacheva, Elena N., Qian, Yong, Guo, Nancy Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342177/
https://www.ncbi.nlm.nih.gov/pubmed/37445737
http://dx.doi.org/10.3390/ijms241310561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342177/
https://www.ncbi.nlm.nih.gov/pubmed/37445737
http://dx.doi.org/10.3390/ijms241310561

Ejemplares similares